Article
Chybowska AD, Vernardis S, McCartney DL, Mur J, Robertson J, Smith HM, Campbell A, Drake C, Grant H, Adkin P, White M, Messner CB, Grauslys A, Andrejev S, Brigden C, Porteous DJ, Hayward C, Price JF, Evans KL, Zelezniak A, Ralser M and Marioni RE
medRxiv (preprint)
In 8,343 participants followed for up to 17 years, the study links high-abundance serum proteins with cardiovascular outcomes and mortality and develops a proteomic risk score. The work was carried out with Eliptica’s involvement and demonstrates how population-scale serum proteomics can support cardiovascular risk stratification and biomarker discovery.
Back to news